NCT06638151 Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) Status RECRUITING Phase PHASE2
NCT06548971 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) Status RECRUITING Phase PHASE3
NCT06531525 Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency Status NOT_YET_RECRUITING Phase PHASE2
NCT06530537 Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds Status RECRUITING Phase PHASE3
NCT06494878 The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Status NOT_YET_RECRUITING Phase PHASE3
NCT06486792 Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation Status NOT_YET_RECRUITING Phase PHASE4
NCT06478537 TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination Status RECRUITING Phase PHASE2
NCT06451198 IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome Status RECRUITING Phase PHASE4
NCT06444178 Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06378398 A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy Status COMPLETED Phase EARLY_PHASE1
NCT06108947 Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks Status RECRUITING Phase NA
NCT06090890 Anti-inflammatory Therapy for Recurrent In-stent Restenosis Status RECRUITING Phase PHASE4
NCT06088433 Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT06018688 Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. Status NOT_YET_RECRUITING Phase PHASE2